Atul Pathak

Atul Pathak, PhD, MBA, is a seasoned professional in pharmaceutical product development with extensive experience in program management and strategic oversight across multiple organizations. Currently serving as a Strategic Program Manager at X4 Pharmaceuticals and a Director in Program Management at Keros Therapeutics, Atul has previously held significant leadership roles at BioMedica Diagnostics Inc., American Regent, Inc., and BioVectra Inc. Atul's expertise encompasses drug regulatory strategy, project management, and the optimization of research and development efforts, with a focus on enhancing efficiency and quality in drug development processes. Educational credentials include an Executive MBA from the University of Prince Edward Island, a PhD in Pharmaceutical Science from CSIR, and post-doctoral research at Harvard Medical School, complementing a robust foundation in pharmacy and intellectual property rights.